No spam - just the good stuff
Subscribe to our newsletter
First Name
(Required)
Email Address
(Required)
Hidden
Contact Source
News
Investor Portal
Lifestyle
Videos
Search for:
Search
More
Contact
Features
News
Home
Biotech
Investment
Diagnostics
Agetech
Supplements
Innovation
AI/Digital
Economy
‘We are so close to the future we want’
Age1's General Partner Alex Colville on why moonshots have a superpower that is derisking longevity investing.
Biotech
Economy
Features
Investment
Investment
ExcepGen emerges from stealth, targets genetic medicine revolution
Biotech
Investment
Investment
‘It’s always too early to say something’s impossible’
Videos
Rejuvenate Biomed announces positive results from sarcopenia clinical trial
Biotech
Scientific leaders issue global Dublin Longevity Declaration
Economy
Mogrify boosts Series A to $46m to advance cellular reprogramming therapies
Biotech
Investment
Investment
Investigating age-related methylation changes across the whole genome
Features
Laverock lands £13.5m to advance gene silencing technology
Investment
Investment
Standing at the precipice of a biotech renaissance – the confluence of AI and SynBio
AI/Digital
Biotech
Features
US government backs thymus rejuvenation project with $37m ARPA-H funding
Innovation
Investment
Investment
Insilico uses Microsoft’s BioGPT to find targets for aging and disease
AI/Digital
Africa’s quest for healthy longevity
Economy
Novo Nordisk Foundation’s new €127m cell therapy facility targets chronic disease
Investment
Investment
Most Popular
Longevity investment bulletin: NewLimit, ORA, Insilico Medicine and more
Investment
Investment
Stay cool: the longevity tech that “shows insane promise”
Features
Videos
Does SIRT6 hold the key to human longevity?
Biotech
Tally up! Consumer longevity company lands $10m
Diagnostics
Investment
Investment
Innovation
US government backs thymus rejuvenation project with $37m ARPA-H funding
Thymus Rejuvenation project led by Thymmune Therapeutics aims to restore damaged or non-functional thymus tissue.
‘Data-driven health is going to be the biggest revolution in the history of medicine’
The Buck and Phenome Health join forces on a data-driven approach to understanding aging biology and improving human healthspan.
Researchers land $3.2m to study impact of microbiome disruption on Alzheimer’s
Researchers at the University of Alabama to investigate the effects of microbiome disruption on Alzheimer’s disease progression.
Will psychedelics produce the next longevity drug?
Dr Halland Chen on longevity medicine, mindset and the potential of psychedelics to improve human longevity.
Economy
‘We are so close to the future we want’
Scientific leaders issue global Dublin Longevity Declaration
Africa’s quest for healthy longevity
SenoClock Gold: Bringing the antiaging paradigm to work
VitaDAO and GlycanAge explore longevity and DeSci in Abu Dhabi event
Longevity.Technology announces entry into Asia Pacific markets
Supplements
NMN Bio and Aster Pharmacy unite to bring antiaging supplements to UAE market
Partnership aims to set a new standard for health and wellness in the United Arab Emirates.
Supplements
First-ever clinical trial of ketone supplementation to treat and prevent frailty
Supplements
Thorne to be acquired by L Catterton for $680 million in cash
Supplements
Researchers develop compound that prevents free radical production in mitochondria
Supplements
Avea secures $5 million in seed funding
Supplements
Longevity: This time it’s personal
Supplements
Taurine deficiency: New research identifies possible driver for aging
Supplements
A strong patent portfolio delivers a competitive edge in the longevity space
Supplements
Combilytics: Taking a combined approach to senescence
Supplements
Editor's pick
‘Data-driven health is going to be the biggest revolution in the history of medicine’
Innovation
Leveraging the past to illuminate longevity for the future
Features
Innovation
Investment
Investment
‘It’s always too early to say something’s impossible’
Videos
‘Longevity is the biggest revolution in the history of Homo sapiens – don’t die!’
Features
Videos
Investment
‘We are so close to the future we want’
Age1's General Partner Alex Colville on why moonshots have a superpower that is derisking longevity investing.
ExcepGen emerges from stealth, targets genetic medicine revolution
Genetic medicine startup on a mission to “massively expand” the reach of DNA and RNA-based genetic medicines.
Mogrify boosts Series A to $46m to advance cellular reprogramming therapies
Company’s technology enables direct in vivo transdifferentiation between any source cell type and any target cell type of clinical interest.
Laverock lands £13.5m to advance gene silencing technology
British gene-silencing technology company Laverock Therapeutics has secured £13.5 million in a seed funding round.
Diagnostics
FDA clears AI tool for early Alzheimer’s detection from MRI scans
New panel set to aid detection of inflammation and biological stress biomarkers
Sonera exits stealth with $11m for neural sensing chip technology
New blood test detects key indicator of Parkinson’s disease
Viome lands $86.5m and US retail deal for gut health test
Dialing up human longevity
Watch now
‘I want medical tourism to be open to everyone, forever’
BioViva's CEO Liz Parrish on de-risking regulatory systems and creating evidence-based medicine from medical tourism.
Videos
‘We are information machines – and it’s time to renew the code.’
Videos
‘It’s always too early to say something’s impossible’
Videos
‘We’re at the longevity inflection point – and the explosion is coming.’
Videos
Longevity to a sirtuin extent
Videos
‘Longevity is the biggest revolution in the history of Homo sapiens – don’t die!’
Videos
Longevity: This time it’s personal
Videos
SIRT6: The protein that talks the talk and walks the walk
Videos
Navigate the emerging field of longevity
Videos
Agetech
Physicians want AI tech to help dementia patients live longer
Two-thirds of UK GPs want to prescribe tech for their dementia patients to help them remain independent and live longer.
Connected technologies are changing the future of aging at home
Huong Le Dieu, Lead Product Manager of BLabs at Baracoda Daily Healthtech, on why it's time to take aging in place to the next level.
AI innovations to transform living with dementia awarded £1.9 million
Longitude Prize on Dementia champions personalized tech that to helps people living with dementia enjoy independent and fulfilled lives.
Clearday and Viveon Health SPAC announce merger agreement to accelerate innovative longevity tech
Definitive merger agreement set to accelerate robotic companion care/AI longevity tech platform to market.
Biotech
‘We are so close to the future we want’
ExcepGen emerges from stealth, targets genetic medicine revolution
Rejuvenate Biomed announces positive results from sarcopenia clinical trial
Mogrify boosts Series A to $46m to advance cellular reprogramming therapies
Standing at the precipice of a biotech renaissance – the confluence of AI and SynBio
Vincere lands grant funding for research into mitophagy enhancing Parkinson’s drug
AI/Digital
Standing at the precipice of a biotech renaissance – the confluence of AI and SynBio
Insilico uses Microsoft’s BioGPT to find targets for aging and disease
Physicians want AI tech to help dementia patients live longer
Insilico and University of Cambridge present new approach for discovering targets for Alzheimer’s